Enhance your end-to-end supply chain with CordenPharma’s Fully Integrated Supply services spanning the manufacturing of Peptide APIs to Sterile Injectables and Lipid Excipients to Lipid NanoParticle (LNP) Formulation of Injectable Drug Products.
Although end-to-end visibility should be the key driver of the supply chain, it is often currently missing, or rather fragmented and unclear. Clarity doesn’t necessarily relate to which stakeholder is producing which product in the chain, but more importantly tied to management of the quality and regulatory aspects associated with various manufacturing process changes and their impact on the final product. This landscape thus demands very close collaboration and transparency between all stakeholders involved.
CordenPharma has the privilege of being one of the few CDMOs in the industry with both end-to-end Fully-Integrated Supply services and backward integration of critical starting materials, available through our sister company Weylchem. This has proven to reduce complexity in customers’ supply chains and bring faster speeds to market.
We believe our Integrated Supply solution to be an effective guide for all types of customers, from virtual biotechs to big pharma, at every step along your outsourcing path, from the manufacturing of back-integrated non-GMP starting materials through pre-clinical & commercial development and manufacturing of GMP intermediates, APIs, Excipients, finished dosage Drug Products & Packaging.
Our Integrated Supply Offering
- Raw Materials and Regulatory Starting Materials from our sister company Weylchem
- Small Molecules APIs to Oral Solid Dosage Drug Products, for efficient and reliable clinical & commercial supply
- Peptide APIs to Sterile Injectable Drug Products, with peptide development & commercial manufacturing capacity, and sterile Fill & Finish vial & Pre-Filled Syringe cartridges
- Lipid Excipients to Lipid NanoParticle (LNP) Formulation for Injectable Drug Products, with greater manufacturing capacity for both, ideal for vaccine development
- Highly Potent APIs to Oral Solid Dosage Drug Products, with development & commercial capacity for tablets and coated tablets
- Secondary Packaging
- Logistic Supply to Clinical Center
Your Integrated Supply Benefit
- Shorter Time-to-Market with overall shorter development & manufacturing timelines
- De-risking the Supply Chain
- Harmonized Quality System & Project Management Organization
- Reduced customer project management resources
- Cost savings (audit, QC release, project management)
- One dedicated Project Manager
Through our network of eight integrated cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides, Lipids & Carbohydrates, Highly Potent & Oncology, Injectables, Small Molecules – we have fostered an efficient exchange between API & Drug Product teams to decrease your development time to market.
Join us In-Person at CPhI Worldwide – Stand 11F30 (Nov 9-11) or EuroTides – Stand 57 (Nov 15-17) to discuss our Fully-Integrated Supply offerings.
